Wildy logo
(020) 7242 5778

Wildy’s Book News

Book News cover photo

Vol 21 No 9 Sept/Oct 2016

Book of the Month

Cover of Goode on Commercial Law

Goode on Commercial Law

Edited by: Ewan McKendrick
Price: £170.00

Pupillage & Student Offers

Special Discounts for Pupils, Newly Called & Students

Read More ...

Secondhand & Out of Print

Browse Secondhand Online


Incentives for Global Public Health: Patent Law and Access to Essential Medicines

ISBN13: 9781107693456
Published: February 2014
Publisher: Cambridge University Press
Country of Publication: USA
Format: Paperback (Hardback in 2010)
Price: £29.99
Hardback edition , ISBN13 9780521116565

Despatched in 7 to 9 days.

This portrait of the global debate over patent law and access to essential medicines focuses on public health concerns about HIV/AIDS, malaria, tuberculosis, the SARS virus, influenza, and diseases of poverty. The essays explore the diplomatic negotiations and disputes in key international fora, such as the World Trade Organization, the World Health Organization and the World Intellectual Property Organization. Drawing upon international trade law, innovation policy, intellectual property law, health law, human rights and philosophy, the authors seek to canvass policy solutions which encourage and reward worthwhile pharmaceutical innovation while ensuring affordable access to advanced medicines. A number of creative policy options are critically assessed, including the development of a Health Impact Fund, prizes for medical innovation, the use of patent pools, open-source drug development and forms of ‘creative capitalism’.

International Trade
Introduction: access to essential medicines: public health and international law Thomas Pogge, Matthew Rimmer and Kim Rubenstein

Part I. International Trade:
1. TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis Rochelle Cooper Dreyfuss
2. The TRIPS waiver as a recognition of public health concerns in the WTO Andrew Mitchell and Tania Voon
3. Public law challenges to the regulation of pharmaceutical patents in the US Bilateral Free Trade Agreements Hitoshi Nasu
4. Global health and development: patents and public interest Elizabeth Siew Kuan Ng

Part II. Innovation:
5. The Health Impact Fund: boosting innovation without obstructing free access Thomas Pogge
6. The Health Impact Fund: a critique Kathleen Liddell
7. A prize system as a partial solution to the health crisis in the developing world William W. Fisher and Talha Syed
8. Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation Thomas Faunce

Part III. Intellectual Property:
9. Opening the dam: patent pools, innovation, and access to essential medicines Dianne Nicol and Jane Nielsen
10. Open source drug discovery: a revolutionary paradigm or a utopian model? Krishna Ravi Srinivas
11. Accessing and benefit sharing avian influenza viruses through the World Health Organization: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? Charles Lawson and Barbara Hocking
12. The Lazarus effect: the (RED) campaign and creative capitalism Matthew Rimmer

Part IV. Health-Care:
13. Beyond TRIPS: the role of non-state actors and access to essential medicines Noah Benjamin Novogrodsky
14. Securing health through rights Katharine Young
15. The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India Rajshree Chandra
16. Tipping point: Thai compulsory licenses redefine essential medicines debate Jonathan Burton-MacLeod.